Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Clinical trial NCT05022797 · TERMINATED

Trial details

NCT number: NCT05022797
Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma Drug Toxicity

Start date: 2021-07-19
Primary completion: 2022-11-22
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.